Hassan Ahmed A, Omar Saeed M, Abdelbagi Omer, Adam Ishag
Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Faculty of Medicine and Health Science, Gadarif University, Gadarif, Sudan.
SAGE Open Nurs. 2024 Jul 25;10:23779608241265203. doi: 10.1177/23779608241265203. eCollection 2024 Jan-Dec.
Diabetes mellitus (DM) is one of the world's major public health problems. There are few published data on 25-hydroxyvitamin D (25[OH]D) concentrations and DM, and these studies showed different results.
The current study aimed to compare 25[OH]D concentrations between patients with type 2 DM (T2DM) and healthy controls in eastern Sudan.
A case-control study of two groups matched for age and gender (88 in each group) was conducted in eastern Sudan from March to May 2022. The cases were patients with T2DM, and the controls were healthy participants. Sociodemographic data were collected, and serum 25(OH)D levels were assessed. A univariate analysis was performed.
Of the total 176, 82 (47%) were males, and 94 (53%) were females; the median (interquartile range [IQR]) of age, body mass index (BMI), and 25(OH)D concentration were 55 (50-61) years, 27 (23-31) kg/m, and 13 (10-19) ng/mL, respectively. Of the 176, 137 (78%) were vitamin D deficiency cases. Compared with the controls, age, gender, educational level, marital status, or BMI were not different in the circumstances. Moreover, the median (IQR) for serum 25(OH)D concentrations showed no difference between patients with T2DM and the healthy controls (12 [10-18] ng/mL vs. 13 [10-20] ng/mL). The prevalence of vitamin D deficiency (25(OH)D level < 20 ng/mL) was not different between patients with T2DM and the healthy controls (66/88 [75%] vs. 71/88 [81%]). There was no association in the serum 25(OH)D levels between diabetic and nondiabetic participants (OR = 1.01, 95% CI 0.97-1.06) or in vitamin D deficiency between diabetic and nondiabetic participants (OR = 0.72, 95% CI 0.35-1.47).
There was no significant difference in 25(OH)D levels between diabetic and nondiabetic participants in this study. Further studies investigating the mechanisms of association between 25(OH)D levels and DM are needed.
糖尿病是世界主要公共卫生问题之一。关于25-羟基维生素D(25[OH]D)浓度与糖尿病的已发表数据较少,且这些研究结果各异。
本研究旨在比较苏丹东部2型糖尿病(T2DM)患者与健康对照者的25[OH]D浓度。
2022年3月至5月在苏丹东部进行了一项病例对照研究,两组按年龄和性别匹配(每组88人)。病例为T2DM患者,对照为健康参与者。收集社会人口学数据,并评估血清25(OH)D水平。进行单因素分析。
176人中,82人(47%)为男性,94人(53%)为女性;年龄、体重指数(BMI)和25(OH)D浓度的中位数(四分位间距[IQR])分别为55(50 - 61)岁、27(23 - 31)kg/m²和13(10 - 19)ng/mL。176人中,137人(78%)为维生素D缺乏病例。与对照组相比,在年龄、性别、教育水平、婚姻状况或BMI方面,两组无差异。此外,T2DM患者与健康对照者血清25(OH)D浓度的中位数(IQR)无差异(12 [10 - 18] ng/mL对13 [10 - 20] ng/mL)。T2DM患者与健康对照者维生素D缺乏(25(OH)D水平<20 ng/mL)的患病率无差异(66/88 [75%]对71/88 [81%])。糖尿病参与者与非糖尿病参与者的血清25(OH)D水平之间无关联(OR = 1.01,95% CI 0.97 - 1.06),糖尿病参与者与非糖尿病参与者之间的维生素D缺乏也无关联(OR = 0.72,95% CI 0.35 - 1.47)。
本研究中糖尿病参与者与非糖尿病参与者的25(OH)D水平无显著差异。需要进一步研究探讨25(OH)D水平与糖尿病之间的关联机制。